Completed NA INTERVENTIONAL NCT05651581

Efficacy and Acceptability of a Monkeypox Curriculum for Disproportionately Impacted Communities

Sponsor: University of Minnesota

Updated 7 times since 2023 Last updated: Oct 3, 2023 Started: May 24, 2023 Primary completion: Aug 24, 2023 Completion: Aug 24, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Monkey Pox, this trial is completed. The trial is conducted by University of Minnesota and has accumulated 7 data snapshots since 2023. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Nov 2023 — Jul 2024 [monthly]

Completed NA

Status: Recruiting → Completed
Jun 2023 — Nov 2023 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Apr 2023 — Jun 2023 [monthly]

Not Yet Recruiting NA

▶ Show 2 earlier versions

Mar 2023 — Apr 2023 [monthly]

Not Yet Recruiting NA
Jan 2023 — Mar 2023 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Minnesota

Data source: University of Minnesota

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Minneapolis, United States